Investors Hangout Stock Message Boards Logo
  • Home
  • Mailbox
  • Boards
  • Favorites
  • Whats Hot!
  • Login - Join Now!
Profile
ohm20's Profile
Displaying 3901-3950 of 6028 result(s).
CYDY CytoDyn Inc
02/22/2021 10:19:56 AM
That he had to let everyone know "D (3)
CYDY CytoDyn Inc
02/22/2021 10:05:14 AM
There is no cake. Have you sold alr (2)
CYDY CytoDyn Inc
02/22/2021 10:03:05 AM
Looking at the list of material dis (6)
CYDY CytoDyn Inc
02/22/2021 8:01:02 AM
A dwarf gymnast with to much CYDY? (5)
CYDY CytoDyn Inc
02/22/2021 7:59:44 AM
They may have topline but as the PR (9)
CYDY CytoDyn Inc
02/22/2021 7:42:36 AM
If the ongoing discussions they men (1)
CYDY CytoDyn Inc
02/22/2021 7:34:45 AM
Unblinding itself would not be a ma (1)
CYDY CytoDyn Inc
02/22/2021 7:31:20 AM
I really don't think there will be
CYDY CytoDyn Inc
02/22/2021 7:23:20 AM
announced today the CD12 COVID-19 t (5)
CYDY CytoDyn Inc
02/22/2021 7:12:53 AM
With the way Nader tiptoes around t (4)
CYDY CytoDyn Inc
02/22/2021 7:09:07 AM
Where's a PR, where's a PR! Why did (10)
CYDY CytoDyn Inc
02/22/2021 7:06:51 AM
Is it not possible that the unblind (1)
CYDY CytoDyn Inc
02/22/2021 7:04:23 AM
After all the flack Nader got becau (2)
CYDY CytoDyn Inc
02/22/2021 7:00:59 AM
Send him an email.
CYDY CytoDyn Inc
02/22/2021 6:42:47 AM
They announced today that results h (3)
CYDY CytoDyn Inc
02/22/2021 6:39:11 AM
Cytodyn - ongoing discussions with (1)
CYDY CytoDyn Inc
02/22/2021 4:51:12 AM
Look at all those interesting cytok (2)
CYDY CytoDyn Inc
02/22/2021 4:33:11 AM
SOD1 mice without microglia have th (1)
CYDY CytoDyn Inc
02/22/2021 4:31:03 AM
So you're telling me that inflammat (1)
CYDY CytoDyn Inc
02/22/2021 4:08:57 AM
Are you invested in HGEN or IPIX? I
CYDY CytoDyn Inc
02/22/2021 3:50:14 AM
So then tell me exactly how SOD1 ca (1)
CYDY CytoDyn Inc
02/22/2021 1:12:07 AM
So tell me again, how YOU propose a
CYDY CytoDyn Inc
02/22/2021 12:09:59 AM
He's never out of ignorance. He has (3)
CYDY CytoDyn Inc
02/22/2021 12:07:42 AM
Modified RNA, and no it won't combi (1)
CYDY CytoDyn Inc
02/21/2021 9:29:33 PM
The .01% difference was because I h (3)
CYDY CytoDyn Inc
02/21/2021 9:20:59 PM
The other theory seems to be that t (2)
CYDY CytoDyn Inc
02/21/2021 5:45:32 PM
94.99% (4)
CYDY CytoDyn Inc
02/21/2021 3:23:35 PM
I believe him and NP will step down (1)
CYDY CytoDyn Inc
02/21/2021 3:21:01 PM
By the time leronlimab has knocked
CYDY CytoDyn Inc
02/21/2021 3:12:52 PM
Epidemiologists consider a minimum (1)
CYDY CytoDyn Inc
02/21/2021 3:00:31 PM
Approximately 10% of amyotrophic la (2)
CYDY CytoDyn Inc
02/21/2021 5:19:37 AM
If you read what you find then you (2)
CYDY CytoDyn Inc
02/21/2021 1:43:42 AM
In disease what happens when you mi
CYDY CytoDyn Inc
02/21/2021 1:13:36 AM
We have a three year contract with (2)
CYDY CytoDyn Inc
02/21/2021 1:07:09 AM
Peer reviewed papers and word of mo (6)
CYDY CytoDyn Inc
02/21/2021 12:35:54 AM
In the 2% of ALS patients with a SO (1)
CYDY CytoDyn Inc
02/20/2021 8:24:40 PM
My understanding from someone who h (5)
CYDY CytoDyn Inc
02/19/2021 7:30:57 PM
That's one I'll have to research ve
CYDY CytoDyn Inc
02/19/2021 5:45:54 PM
A sales and marketing team for the (9)
CYDY CytoDyn Inc
02/19/2021 4:43:07 PM
Inflammatory conditions induce insu (1)
CYDY CytoDyn Inc
02/19/2021 4:39:26 PM
Since they're supposed to be workin (1)
CYDY CytoDyn Inc
02/19/2021 4:37:44 PM
Timelines for trials for MS seem to (1)
CYDY CytoDyn Inc
02/19/2021 4:12:57 PM
Outside of the trials already sched (5)
CYDY CytoDyn Inc
02/19/2021 4:04:33 PM
I expect more trials per year than (1)
CYDY CytoDyn Inc
02/19/2021 3:10:10 PM
It was stated as Reg-Cov2 but only
CYDY CytoDyn Inc
02/19/2021 2:28:58 PM
https://jamanetwork.com/journals/j (2)
CYDY CytoDyn Inc
02/19/2021 1:46:03 PM
I've never claimed to be a doctor. (9)
CYDY CytoDyn Inc
02/19/2021 1:32:57 PM
Ivermectin unless you go severe and (3)
CYDY CytoDyn Inc
02/19/2021 11:25:17 AM
Everyone gets that wrong. It was ac
CYDY CytoDyn Inc
02/19/2021 11:23:31 AM
But comments by NP dating back to t (12)
Go to page:
  • << First
  • < Previous
  • 78
  • 79
  • Next >

Recent Articles

  • The Ongoing Commitment to Sustainability: Business Value and Action
  • VOOPOO Gears Up for InterTabac 2025 Unveiling
  • Columbus A/S Reports on Recent Share Buyback Activities
  • Global Smart City Innovation Showcased at Tomorrow.City 2025
  • Investors Take Action Against Nutex Health Inc. for Fraud
  • Onassis Holdings Teams with Dalmore for $75 Million Offering
  • Investors' Action Plan: Leading Class Lawsuit Against RxSight
  • RxSight, Inc. Faces Investigation for Potential Securities Violations
  • Investors Can Lead Class Action Against Replimune Group, Inc.
  • Alto Neuroscience, Inc. Faces Class Action Lawsuit Risk
  • Luminar Technologies Faces Securities Fraud Lawsuit Challenges
  • Investors Alert: Spectrum Pharmaceuticals Faces Legal Action
  • B2PRIME Sets New Standards with DFSA Licence for Gulf Operations
  • Alm. Brand A/S Enhances Shareholder Value Through Buybacks
  • Unlock Exciting Rewards with HTX's Latest iPhone 17 Promotions
  • Hesai Expands Lidar Partnership with Major Robotaxi Company
  • Dan Ives Predicts Tesla Could Unlock $1 Trillion from AI
  • Onassis Holdings Partners with Dalmore Group for Reg A+ Offering
  • Legal Insights: DJS Law Group's Vigil for LMT Investors
  • Investors Eyeing Sable Offshore Corp. Legal Actions
  • Management Transactions and Share Insights at Danske Bank
  • Tesla's Cybertruck RWD Variant Discontinued: An Analysis of Trends
  • Eric Jackson Discusses Opendoor Technologies as a Cult Stock
  • Hesai Partners with U.S. Robotaxi Firm for $40 Million Lidar Deal
  • Unlock Exciting Rewards with HTX and iPhone 17 Events
  • Statkraft Partners with Serentica for Renewable Energy Growth
  • Exploring Jyske Realkredit's Early Redemption Data Insights
  • Toobit Expands Global Reach at Crypto Summit 2025 in Moscow
  • Mycenax and SPERA PHARMA Join Forces to Advance ADC Manufacturing
  • Motorola Solutions Enhances Communications for Azerbaijan's Safety
  • OxBarrier Unveils Innovative Compostable Capsule Licensing Program
  • Transforming Rural Healthcare: Windom Area Health's Journey
  • OxBarrier's Innovative Licensing Program for Eco-Friendly Capsules
  • Unlocking Growth: V2 Cloud's Revolutionary Partner Initiative
  • Strengthening Connections: 4iG Group and Elisa Polystar Unite
  • Toobit Expands its Global Footprint at Crypto Summit in Russia
  • Nokia and Deutsche Bahn Innovate with First 5G Network for Rail
  • Changes in Hiab’s Shareholders’ Nomination Board Explained
  • Tesla's Future Challenges After Recent Stock Surge
  • FLYW Investors' Rights: Engaging in Flywire Corporation's Case
  • General Mills Faces Analyst Downgrades Ahead of Q1 Earnings
  • Truecaller B Shares Bought Back: Highlights from Week 37
  • EQT Enhances Private Market Access with Innovative ELTIF Fund
  • NKT Named Preferred Bidder for Major HVDC Interconnector Project
  • Totalkredit A/S Prepayment Data and Investor Information
  • Nykredit Realkredit A/S Shares Prepayment Data Update
  • Economic Concerns Heighten as Recession Probability Rises to 48%
  • Important Leadership Changes Ahead of Potential Octave Spin-off
  • Revolutionizing Food Production with Membralox Ceramic Membranes
  • Analyzing Bitcoin's Dips Amid Soaring Stocks and Gold Values
  • Home - Investors HangoutHome

  • Mailbox - Investors HangoutMailbox

  • Boards - Investors HangoutBoards

  • Favorites - Investors HangoutFavorites

  • Whats Hot! - Investors HangoutWhats Hot!

  • More - Investors HangoutMore

  • Settings - Investors HangoutSettings
  • Login - Investors HangoutLogin
  • Live Site - Investors HangoutLive Site